UniProt ID | TCPA_HUMAN | |
---|---|---|
UniProt AC | P17987 | |
Protein Name | T-complex protein 1 subunit alpha | |
Gene Name | TCP1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 556 | |
Subcellular Localization | Cytoplasm. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. | |
Protein Description | Molecular chaperone; assists the folding of proteins upon ATP hydrolysis. As part of the BBS/CCT complex may play a role in the assembly of BBSome, a complex involved in ciliogenesis regulating transports vesicles to the cilia. Known to play a role, in vitro, in the folding of actin and tubulin.. | |
Protein Sequence | MEGPLSVFGDRSTGETIRSQNVMAAASIANIVKSSLGPVGLDKMLVDDIGDVTITNDGATILKLLEVEHPAAKVLCELADLQDKEVGDGTTSVVIIAAELLKNADELVKQKIHPTSVISGYRLACKEAVRYINENLIVNTDELGRDCLINAAKTSMSSKIIGINGDFFANMVVDAVLAIKYTDIRGQPRYPVNSVNILKAHGRSQMESMLISGYALNCVVGSQGMPKRIVNAKIACLDFSLQKTKMKLGVQVVITDPEKLDQIRQRESDITKERIQKILATGANVILTTGGIDDMCLKYFVEAGAMAVRRVLKRDLKRIAKASGATILSTLANLEGEETFEAAMLGQAEEVVQERICDDELILIKNTKARTSASIILRGANDFMCDEMERSLHDALCVVKRVLESKSVVPGGGAVEAALSIYLENYATSMGSREQLAIAEFARSLLVIPNTLAVNAAQDSTDLVAKLRAFHNEAQVNPERKNLKWIGLDLSNGKPRDNKQAGVFEPTIVKVKSLKFATEAAITILRIDDLIKLHPESKDDKHGSYEDAVHSGALND | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MEGPLSVF -------CCCCCEEC | 14.00 | 19413330 | |
1 | Sulfoxidation | -------MEGPLSVF -------CCCCCEEC | 14.00 | 28465586 | |
6 | Phosphorylation | --MEGPLSVFGDRST --CCCCCEECCCCCC | 20.66 | 21406692 | |
11 | Methylation | PLSVFGDRSTGETIR CCEECCCCCCCCCHH | 36.18 | - | |
12 | Phosphorylation | LSVFGDRSTGETIRS CEECCCCCCCCCHHH | 45.57 | 23186163 | |
13 | Phosphorylation | SVFGDRSTGETIRSQ EECCCCCCCCCHHHH | 39.67 | 23186163 | |
19 | Phosphorylation | STGETIRSQNVMAAA CCCCCHHHHHHHHHH | 23.43 | 20068231 | |
23 | Sulfoxidation | TIRSQNVMAAASIAN CHHHHHHHHHHHHHH | 2.49 | 21406390 | |
27 | Phosphorylation | QNVMAAASIANIVKS HHHHHHHHHHHHHHH | 19.94 | 20068231 | |
33 | Ubiquitination | ASIANIVKSSLGPVG HHHHHHHHHCCCCCC | 30.45 | - | |
34 | Phosphorylation | SIANIVKSSLGPVGL HHHHHHHHCCCCCCC | 21.65 | 21712546 | |
35 | Phosphorylation | IANIVKSSLGPVGLD HHHHHHHCCCCCCCC | 31.46 | 21712546 | |
43 | Ubiquitination | LGPVGLDKMLVDDIG CCCCCCCCCEECCCC | 38.89 | - | |
44 | Sulfoxidation | GPVGLDKMLVDDIGD CCCCCCCCEECCCCC | 4.38 | 30846556 | |
55 | Phosphorylation | DIGDVTITNDGATIL CCCCEEEECCCCHHH | 20.21 | 25690035 | |
60 | Phosphorylation | TITNDGATILKLLEV EEECCCCHHHHHHHC | 32.16 | 25690035 | |
63 | Ubiquitination | NDGATILKLLEVEHP CCCCHHHHHHHCCCH | 47.37 | 21906983 | |
73 | Ubiquitination | EVEHPAAKVLCELAD HCCCHHHHHHHHHHC | 37.53 | 21890473 | |
73 | 2-Hydroxyisobutyrylation | EVEHPAAKVLCELAD HCCCHHHHHHHHHHC | 37.53 | - | |
73 | Acetylation | EVEHPAAKVLCELAD HCCCHHHHHHHHHHC | 37.53 | 27452117 | |
76 | S-nitrosocysteine | HPAAKVLCELADLQD CHHHHHHHHHHCCCC | 4.51 | - | |
76 | S-nitrosylation | HPAAKVLCELADLQD CHHHHHHHHHHCCCC | 4.51 | 22178444 | |
84 | Acetylation | ELADLQDKEVGDGTT HHHCCCCCCCCCCHH | 41.14 | 7430915 | |
90 | Phosphorylation | DKEVGDGTTSVVIIA CCCCCCCHHHHHHHH | 22.19 | 30622161 | |
91 | Phosphorylation | KEVGDGTTSVVIIAA CCCCCCHHHHHHHHH | 25.67 | 30622161 | |
92 | Phosphorylation | EVGDGTTSVVIIAAE CCCCCHHHHHHHHHH | 17.77 | 30622161 | |
109 | Ubiquitination | KNADELVKQKIHPTS HCHHHHHHCCCCCCC | 59.50 | 21906983 | |
109 | 2-Hydroxyisobutyrylation | KNADELVKQKIHPTS HCHHHHHHCCCCCCC | 59.50 | - | |
109 | Acetylation | KNADELVKQKIHPTS HCHHHHHHCCCCCCC | 59.50 | 25953088 | |
111 | Ubiquitination | ADELVKQKIHPTSVI HHHHHHCCCCCCCHH | 36.95 | 21906983 | |
111 | 2-Hydroxyisobutyrylation | ADELVKQKIHPTSVI HHHHHHCCCCCCCHH | 36.95 | - | |
115 | Phosphorylation | VKQKIHPTSVISGYR HHCCCCCCCHHCHHH | 22.82 | 23186163 | |
116 | Phosphorylation | KQKIHPTSVISGYRL HCCCCCCCHHCHHHH | 23.16 | 23186163 | |
119 | Phosphorylation | IHPTSVISGYRLACK CCCCCHHCHHHHHHH | 27.84 | 20068231 | |
121 | Phosphorylation | PTSVISGYRLACKEA CCCHHCHHHHHHHHH | 8.82 | 20068231 | |
126 | Ubiquitination | SGYRLACKEAVRYIN CHHHHHHHHHHHHHH | 43.00 | 21906983 | |
126 | 2-Hydroxyisobutyrylation | SGYRLACKEAVRYIN CHHHHHHHHHHHHHH | 43.00 | - | |
131 | Phosphorylation | ACKEAVRYINENLIV HHHHHHHHHHHCCEE | 11.08 | 28152594 | |
147 | S-nitrosocysteine | TDELGRDCLINAAKT HHHHCHHHHHHHHHH | 3.86 | - | |
147 | S-nitrosylation | TDELGRDCLINAAKT HHHHCHHHHHHHHHH | 3.86 | 22178444 | |
147 | S-palmitoylation | TDELGRDCLINAAKT HHHHCHHHHHHHHHH | 3.86 | 26865113 | |
153 | Ubiquitination | DCLINAAKTSMSSKI HHHHHHHHHCCCCCC | 38.43 | - | |
153 | 2-Hydroxyisobutyrylation | DCLINAAKTSMSSKI HHHHHHHHHCCCCCC | 38.43 | - | |
153 | Acetylation | DCLINAAKTSMSSKI HHHHHHHHHCCCCCC | 38.43 | 25953088 | |
157 | Phosphorylation | NAAKTSMSSKIIGIN HHHHHCCCCCCCCCC | 28.39 | - | |
158 | Phosphorylation | AAKTSMSSKIIGING HHHHCCCCCCCCCCC | 21.16 | - | |
181 | Phosphorylation | DAVLAIKYTDIRGQP HHHHEEEEECCCCCC | 11.97 | 28152594 | |
182 | Phosphorylation | AVLAIKYTDIRGQPR HHHEEEEECCCCCCC | 21.68 | 28152594 | |
185 | Methylation | AIKYTDIRGQPRYPV EEEEECCCCCCCCCC | 40.27 | - | |
190 | Phosphorylation | DIRGQPRYPVNSVNI CCCCCCCCCCCHHHH | 20.44 | 28152594 | |
194 | Phosphorylation | QPRYPVNSVNILKAH CCCCCCCHHHHHHHC | 19.44 | 23312004 | |
199 | Methylation | VNSVNILKAHGRSQM CCHHHHHHHCCHHHH | 34.24 | 19608861 | |
199 | Acetylation | VNSVNILKAHGRSQM CCHHHHHHHCCHHHH | 34.24 | 19608861 | |
199 | Ubiquitination | VNSVNILKAHGRSQM CCHHHHHHHCCHHHH | 34.24 | 19608861 | |
199 | Malonylation | VNSVNILKAHGRSQM CCHHHHHHHCCHHHH | 34.24 | 26320211 | |
204 | Phosphorylation | ILKAHGRSQMESMLI HHHHCCHHHHHHHHH | 38.17 | 25072903 | |
208 | Phosphorylation | HGRSQMESMLISGYA CCHHHHHHHHHHHHH | 17.34 | 26126808 | |
212 | Phosphorylation | QMESMLISGYALNCV HHHHHHHHHHHHHCC | 23.07 | 25072903 | |
214 | Phosphorylation | ESMLISGYALNCVVG HHHHHHHHHHHCCCC | 10.92 | 25072903 | |
218 | Glutathionylation | ISGYALNCVVGSQGM HHHHHHHCCCCCCCC | 2.46 | 22555962 | |
222 | Phosphorylation | ALNCVVGSQGMPKRI HHHCCCCCCCCCHHH | 16.38 | 25072903 | |
227 | Acetylation | VGSQGMPKRIVNAKI CCCCCCCHHHHCCEE | 45.95 | 26051181 | |
233 | Ubiquitination | PKRIVNAKIACLDFS CHHHHCCEEEEEEHH | 26.15 | - | |
233 | Acetylation | PKRIVNAKIACLDFS CHHHHCCEEEEEEHH | 26.15 | 25953088 | |
236 | S-nitrosocysteine | IVNAKIACLDFSLQK HHCCEEEEEEHHCHH | 4.22 | - | |
236 | Glutathionylation | IVNAKIACLDFSLQK HHCCEEEEEEHHCHH | 4.22 | 22555962 | |
236 | S-nitrosylation | IVNAKIACLDFSLQK HHCCEEEEEEHHCHH | 4.22 | 19483679 | |
240 | Phosphorylation | KIACLDFSLQKTKMK EEEEEEHHCHHCCCC | 29.56 | 25159151 | |
243 | Ubiquitination | CLDFSLQKTKMKLGV EEEHHCHHCCCCCCE | 56.24 | - | |
243 | 2-Hydroxyisobutyrylation | CLDFSLQKTKMKLGV EEEHHCHHCCCCCCE | 56.24 | - | |
243 | Acetylation | CLDFSLQKTKMKLGV EEEHHCHHCCCCCCE | 56.24 | 25953088 | |
245 | Acetylation | DFSLQKTKMKLGVQV EHHCHHCCCCCCEEE | 40.86 | - | |
245 | Ubiquitination | DFSLQKTKMKLGVQV EHHCHHCCCCCCEEE | 40.86 | - | |
247 | Ubiquitination | SLQKTKMKLGVQVVI HCHHCCCCCCEEEEE | 43.58 | - | |
255 | Phosphorylation | LGVQVVITDPEKLDQ CCEEEEECCHHHHHH | 33.61 | 23532336 | |
259 | Acetylation | VVITDPEKLDQIRQR EEECCHHHHHHHHHH | 63.85 | 25953088 | |
259 | Ubiquitination | VVITDPEKLDQIRQR EEECCHHHHHHHHHH | 63.85 | 21906983 | |
268 | Phosphorylation | DQIRQRESDITKERI HHHHHHCCHHCHHHH | 36.18 | 22210691 | |
296 | Glutathionylation | TGGIDDMCLKYFVEA CCCHHHHHHHHHHHH | 3.69 | 22555962 | |
299 | Phosphorylation | IDDMCLKYFVEAGAM HHHHHHHHHHHHHHH | 10.42 | 19534553 | |
306 | Sulfoxidation | YFVEAGAMAVRRVLK HHHHHHHHHHHHHHH | 3.29 | 30846556 | |
344 | Sulfoxidation | EETFEAAMLGQAEEV HHHHHHHHHCCHHHH | 5.79 | 28183972 | |
357 | S-nitrosocysteine | EVVQERICDDELILI HHHHHHCCCCEEEEE | 7.26 | - | |
357 | Glutathionylation | EVVQERICDDELILI HHHHHHCCCCEEEEE | 7.26 | 22555962 | |
357 | S-nitrosylation | EVVQERICDDELILI HHHHHHCCCCEEEEE | 7.26 | 18335467 | |
365 | Acetylation | DDELILIKNTKARTS CCEEEEEECCCCCCC | 55.93 | 23749302 | |
365 | Ubiquitination | DDELILIKNTKARTS CCEEEEEECCCCCCC | 55.93 | - | |
365 | 2-Hydroxyisobutyrylation | DDELILIKNTKARTS CCEEEEEECCCCCCC | 55.93 | - | |
367 | Phosphorylation | ELILIKNTKARTSAS EEEEEECCCCCCCCH | 22.53 | 23898821 | |
368 | Ubiquitination | LILIKNTKARTSASI EEEEECCCCCCCCHH | 45.31 | - | |
371 | Phosphorylation | IKNTKARTSASIILR EECCCCCCCCHHHHC | 33.24 | 21406692 | |
372 | Phosphorylation | KNTKARTSASIILRG ECCCCCCCCHHHHCC | 17.92 | 21406692 | |
374 | Phosphorylation | TKARTSASIILRGAN CCCCCCCHHHHCCCC | 15.21 | 21406692 | |
384 | Sulfoxidation | LRGANDFMCDEMERS HCCCCCHHCHHHHHH | 2.91 | 21406390 | |
385 | Glutathionylation | RGANDFMCDEMERSL CCCCCHHCHHHHHHH | 3.96 | 22555962 | |
388 | Sulfoxidation | NDFMCDEMERSLHDA CCHHCHHHHHHHHHH | 3.11 | 30846556 | |
397 | S-nitrosocysteine | RSLHDALCVVKRVLE HHHHHHHHHHHHHHH | 3.38 | - | |
397 | Glutathionylation | RSLHDALCVVKRVLE HHHHHHHHHHHHHHH | 3.38 | 22555962 | |
397 | S-nitrosylation | RSLHDALCVVKRVLE HHHHHHHHHHHHHHH | 3.38 | 19483679 | |
400 | Acetylation | HDALCVVKRVLESKS HHHHHHHHHHHHCCC | 19.18 | 19608861 | |
400 | Ubiquitination | HDALCVVKRVLESKS HHHHHHHHHHHHCCC | 19.18 | 19608861 | |
400 | 2-Hydroxyisobutyrylation | HDALCVVKRVLESKS HHHHHHHHHHHHCCC | 19.18 | - | |
400 | Malonylation | HDALCVVKRVLESKS HHHHHHHHHHHHCCC | 19.18 | 26320211 | |
405 | Phosphorylation | VVKRVLESKSVVPGG HHHHHHHCCCCCCCC | 26.52 | 22210691 | |
422 | Phosphorylation | VEAALSIYLENYATS HHHHHHHHHHHHHHC | 12.46 | 22210691 | |
428 | Phosphorylation | IYLENYATSMGSREQ HHHHHHHHCCCCHHH | 14.64 | 22210691 | |
429 | Phosphorylation | YLENYATSMGSREQL HHHHHHHCCCCHHHH | 16.99 | 24275569 | |
443 | Methylation | LAIAEFARSLLVIPN HHHHHHHHHHCCCCC | 32.91 | - | |
444 | Phosphorylation | AIAEFARSLLVIPNT HHHHHHHHHCCCCCH | 23.72 | 21712546 | |
460 | Phosphorylation | AVNAAQDSTDLVAKL HHCCCCCCHHHHHHH | 16.25 | 21712546 | |
466 | Ubiquitination | DSTDLVAKLRAFHNE CCHHHHHHHHHHHHH | 30.90 | 21906983 | |
466 | Acetylation | DSTDLVAKLRAFHNE CCHHHHHHHHHHHHH | 30.90 | 23236377 | |
468 | Methylation | TDLVAKLRAFHNEAQ HHHHHHHHHHHHHHC | 34.20 | - | |
481 | Ubiquitination | AQVNPERKNLKWIGL HCCCCCCCCCEEEEE | 66.04 | - | |
484 | Acetylation | NPERKNLKWIGLDLS CCCCCCCEEEEEECC | 46.27 | 23749302 | |
484 | Ubiquitination | NPERKNLKWIGLDLS CCCCCCCEEEEEECC | 46.27 | 21890473 | |
491 | Phosphorylation | KWIGLDLSNGKPRDN EEEEEECCCCCCCCC | 43.11 | 28450419 | |
494 | Acetylation | GLDLSNGKPRDNKQA EEECCCCCCCCCCCC | 40.92 | 26051181 | |
494 | Ubiquitination | GLDLSNGKPRDNKQA EEECCCCCCCCCCCC | 40.92 | 21890473 | |
494 | Malonylation | GLDLSNGKPRDNKQA EEECCCCCCCCCCCC | 40.92 | 26320211 | |
499 | Ubiquitination | NGKPRDNKQAGVFEP CCCCCCCCCCCCCCC | 45.90 | - | |
499 | 2-Hydroxyisobutyrylation | NGKPRDNKQAGVFEP CCCCCCCCCCCCCCC | 45.90 | - | |
499 | Malonylation | NGKPRDNKQAGVFEP CCCCCCCCCCCCCCC | 45.90 | 26320211 | |
499 | Acetylation | NGKPRDNKQAGVFEP CCCCCCCCCCCCCCC | 45.90 | 25953088 | |
510 | Ubiquitination | VFEPTIVKVKSLKFA CCCCEEEEEECCCCH | 39.84 | - | |
510 | Acetylation | VFEPTIVKVKSLKFA CCCCEEEEEECCCCH | 39.84 | 25953088 | |
512 | Ubiquitination | EPTIVKVKSLKFATE CCEEEEEECCCCHHH | 44.33 | - | |
513 | Phosphorylation | PTIVKVKSLKFATEA CEEEEEECCCCHHHH | 39.52 | 24719451 | |
515 | Ubiquitination | IVKVKSLKFATEAAI EEEEECCCCHHHHHH | 39.79 | - | |
532 | Acetylation | LRIDDLIKLHPESKD EEHHHHHHHCCCCCC | 48.30 | 23954790 | |
532 | Ubiquitination | LRIDDLIKLHPESKD EEHHHHHHHCCCCCC | 48.30 | 21890473 | |
532 | 2-Hydroxyisobutyrylation | LRIDDLIKLHPESKD EEHHHHHHHCCCCCC | 48.30 | - | |
532 | Malonylation | LRIDDLIKLHPESKD EEHHHHHHHCCCCCC | 48.30 | 26320211 | |
537 | Phosphorylation | LIKLHPESKDDKHGS HHHHCCCCCCCCCCC | 45.92 | 23401153 | |
538 | Acetylation | IKLHPESKDDKHGSY HHHCCCCCCCCCCCH | 69.18 | 23749302 | |
538 | Ubiquitination | IKLHPESKDDKHGSY HHHCCCCCCCCCCCH | 69.18 | 21906983 | |
541 | Acetylation | HPESKDDKHGSYEDA CCCCCCCCCCCHHHH | 61.06 | 23954790 | |
541 | Ubiquitination | HPESKDDKHGSYEDA CCCCCCCCCCCHHHH | 61.06 | 21890473 | |
541 | 2-Hydroxyisobutyrylation | HPESKDDKHGSYEDA CCCCCCCCCCCHHHH | 61.06 | - | |
541 | Malonylation | HPESKDDKHGSYEDA CCCCCCCCCCCHHHH | 61.06 | 26320211 | |
544 | Phosphorylation | SKDDKHGSYEDAVHS CCCCCCCCHHHHHHH | 25.68 | 22167270 | |
545 | Phosphorylation | KDDKHGSYEDAVHSG CCCCCCCHHHHHHHC | 23.55 | 22167270 | |
551 | Phosphorylation | SYEDAVHSGALND-- CHHHHHHHCCCCC-- | 21.11 | 25159151 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TCPA_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TCPA_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TCPA_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TCPB_HUMAN | CCT2 | physical | 16085932 | |
TCPG_HUMAN | CCT3 | physical | 16085932 | |
TCPD_HUMAN | CCT4 | physical | 16085932 | |
TCPE_HUMAN | CCT5 | physical | 16085932 | |
TCPZ_HUMAN | CCT6A | physical | 16085932 | |
TCPH_HUMAN | CCT7 | physical | 16085932 | |
TCPQ_HUMAN | CCT8 | physical | 16085932 | |
GLCM_HUMAN | GBA | physical | 21098288 | |
VHL_HUMAN | VHL | physical | 14636579 | |
PACRG_HUMAN | PACRG | physical | 14532270 | |
TCPB_HUMAN | CCT2 | physical | 14532270 | |
TCPE_HUMAN | CCT5 | physical | 22939629 | |
TCPH_HUMAN | CCT7 | physical | 22939629 | |
TCPB_HUMAN | CCT2 | physical | 22939629 | |
TCPD_HUMAN | CCT4 | physical | 22939629 | |
TCPG_HUMAN | CCT3 | physical | 22939629 | |
TCPZ_HUMAN | CCT6A | physical | 22939629 | |
TCPQ_HUMAN | CCT8 | physical | 22939629 | |
TCPW_HUMAN | CCT6B | physical | 22939629 | |
TCPG_HUMAN | CCT3 | physical | 22863883 | |
PP4C_HUMAN | PPP4C | physical | 22863883 | |
VRK2_HUMAN | VRK2 | physical | 24298020 | |
MTG8R_HUMAN | CBFA2T2 | physical | 25416956 | |
TCPB_HUMAN | CCT2 | physical | 26344197 | |
TCPH_HUMAN | CCT7 | physical | 26344197 | |
TCPQ_HUMAN | CCT8 | physical | 26344197 | |
RPN1_HUMAN | RPN1 | physical | 26344197 | |
QCR2_HUMAN | UQCRC2 | physical | 26344197 | |
ACTB_HUMAN | ACTB | physical | 14532270 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. | |
"Exploring proteomes and analyzing protein processing by massspectrometric identification of sorted N-terminal peptides."; Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,Thomas G.R., Vandekerckhove J.; Nat. Biotechnol. 21:566-569(2003). Cited for: PROTEIN SEQUENCE OF 1-11, AND ACETYLATION AT MET-1. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-199; LYS-400 AND LYS-532,AND MASS SPECTROMETRY. | |
"Substrate and functional diversity of lysine acetylation revealed bya proteomics survey."; Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T.,Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.-J., Zhao Y.; Mol. Cell 23:607-618(2006). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-400, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-544 AND SER-551, ANDMASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-544, AND MASSSPECTROMETRY. | |
"Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-544, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-544, AND MASSSPECTROMETRY. | |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-299, AND MASSSPECTROMETRY. |